Can physician's self‐estimates be used as a valid instrument to determine prescription frequencies of anti‐psoriatic drugs? Comparison of the results of a cross‐sectional study using self‐estimates with actual prescription behavior documented in a cohort study. (17th May 2013)
- Record Type:
- Journal Article
- Title:
- Can physician's self‐estimates be used as a valid instrument to determine prescription frequencies of anti‐psoriatic drugs? Comparison of the results of a cross‐sectional study using self‐estimates with actual prescription behavior documented in a cohort study. (17th May 2013)
- Main Title:
- Can physician's self‐estimates be used as a valid instrument to determine prescription frequencies of anti‐psoriatic drugs? Comparison of the results of a cross‐sectional study using self‐estimates with actual prescription behavior documented in a cohort study
- Authors:
- Nast, Alexander
Rosumeck, Stefanie
Erdmann, Ricardo
Werner, Ricardo N. - Abstract:
- ABSTRACT: Purpose: Physicians' self‐estimates of their own prescription behavior can be used as a tool to gather information on prescription frequencies. Self‐estimates as a tool for health‐care research on prescription frequencies need to be validated as a suitable method before it can be used widely. Methods: We performed a cross‐sectional study inviting all dermatologists in Berlin and Brandenburg to give self‐estimates of their own prescription behavior of anti‐psoriatic drugs. The results were compared with the results from a consecutive 8‐months cohort study with the same participants documenting their actual treatment choices during every visit of a psoriasis patient on a standardized documentation sheet. Differences between self‐estimates and documented prescription patterns were analyzed with respect to systemic anti‐psoriatic drugs and UV treatment. Results: Fifty‐one dermatologists participated. They documented an average of 91 patient visits each. Absolute differences between the self‐estimates and the documented actual prescription behavior ranged from −2.5% to 1.4% for systemic treatments. For psoralen plus ultravioloet A (PUVA) treatment, the absolute difference was 3.3% and for ultraviolet B (UVB) 4.7%. Conclusions: Self‐estimates were surprisingly exact. Self‐estimates may be suggested as one tool to assess prescription frequencies, but further studies are needed to confirm their validity. Copyright © 2013 John Wiley & Sons, Ltd.
- Is Part Of:
- Pharmacoepidemiology and drug safety. Volume 22:Number 11(2013:Nov.)
- Journal:
- Pharmacoepidemiology and drug safety
- Issue:
- Volume 22:Number 11(2013:Nov.)
- Issue Display:
- Volume 22, Issue 11 (2013)
- Year:
- 2013
- Volume:
- 22
- Issue:
- 11
- Issue Sort Value:
- 2013-0022-0011-0000
- Page Start:
- 1154
- Page End:
- 1158
- Publication Date:
- 2013-05-17
- Subjects:
- psoriasis -- evaluation studies -- drug prescriptions -- treatment -- surveys -- pharmacoepidemiology
Pharmacoepidemiology -- Periodicals
Chemotherapy -- Periodicals
Epidemiology -- Periodicals
615.705 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/pds.3453 ↗
- Languages:
- English
- ISSNs:
- 1053-8569
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.248000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 1480.xml